OCC 1.61% 61.0¢ orthocell limited

OCC Trading, page-818

  1. 1,395 Posts.
    lightbulb Created with Sketch. 232
    Agree to disagree

    1. Increase revenue

    2. Distribution agreement / Partnership USA

    Any other announcement is just polished shit, and management love talking shit

    If no news on 1 and 2 by the end of the first quarter, no more bullshit talk how they are still in talks with a few big players. Agreements signed, revenue streaming or time to start sacking, no more option for underperforming or payments for doing sweet FA

    2021 was a big year for Management they all got pay raises, options approved for a underperforming share price

    2022 is going to be the same as the last seven years, our holdings will increase from 197 million to 250 million, our share price will remain the same at under 50 cents, but the companies worth will increase to over 125 million, the next AGM will still be all talk about how they are the next big biotech like PNV, management will ask for pay increases and our new dumb shit institutional investment will agree to it.

    2023 time to sell out
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
61.0¢
Change
-0.010(1.61%)
Mkt cap ! $145.8M
Open High Low Value Volume
62.5¢ 63.0¢ 61.0¢ $1.181M 1.913M

Buyers (Bids)

No. Vol. Price($)
2 5445 61.0¢
 

Sellers (Offers)

Price($) Vol. No.
62.0¢ 10000 1
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.